The proposed legislation, General Assembly Raised Bill No. 6919, mandates the inclusion of Duchenne muscular dystrophy (DMD) in the list of conditions screened for in newborns as part of the state's newborn screening program. Specifically, the bill amends subsection (c) of section 19a-55 of the general statutes, which outlines the conditions for which newborns are screened. The current list includes various disorders, and the bill adds that, effective July 1, 2027, DMD will be included in this screening process.

Additionally, the bill updates the existing language by removing the phrase "and" before the inclusion of cytomegalovirus, which will be screened starting July 1, 2025. The overall aim of the bill is to enhance early detection and intervention for DMD, thereby improving health outcomes for affected newborns. The act is set to take effect on July 1, 2025, with the specific addition of DMD screening commencing two years later.